true 2017-01-01 2017-12-31 false 04945739 uk-bus:Director1 2017-01-01 2017-12-31 04945739 uk-bus:Director2 2017-01-01 2017-12-31 04945739 2017-01-01 2017-12-31 04945739 2017-12-31 04945739 uk-bus:EntityHasNeverTraded 2017-01-01 2017-12-31 04945739 uk-bus:FRS102 2017-01-01 2017-12-31 04945739 uk-bus:FullAccounts 2017-01-01 2017-12-31 04945739 uk-bus:AuditExempt-NoAccountantsReport 2017-01-01 2017-12-31 04945739 2016-12-31 04945739 uk-bus:OrdinaryShareClass1 2017-01-01 2017-12-31 04945739 uk-bus:OrdinaryShareClass2 2017-01-01 2017-12-31 04945739 uk-bus:OrdinaryShareClass3 2017-01-01 2017-12-31 04945739 uk-bus:PreferenceShareClass1 2017-01-01 2017-12-31 04945739 uk-bus:PreferenceShareClass2 2017-01-01 2017-12-31 04945739 uk-bus:PreferenceShareClass3 2017-01-01 2017-12-31 04945739 uk-core:ShareCapitalPreferenceShares 2017-12-31 04945739 uk-core:ShareCapitalPreferenceShares 2016-12-31 iso4217:GBP xbrli:shares

Registered Number 04945739

OCTAPHARMA (IP) LIMITED

Dormant Accounts

31 December 2017

OCTAPHARMA (IP) LIMITED Registered Number 04945739

Balance Sheet as at 31 December 2017

2017 2016
£ £
Called up share capital not paid
100
100
Net assets
100
100
Issued share capital
100 Ordinary Shares of £ 1 each 100 100
Total Shareholder funds
100
100

STATEMENTS

  1. For the year ending 31 December 2017 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 11 September 2018

And signed on their behalf by:
Barbara Rangetiner, Director
Daniel Wyder, Director